Tenn. Code § 20-13-203

Current through Acts 2023-2024, ch. 1069
Section 20-13-203 - Authority of attorney general and reporter to release claims regarding opioids

Upon written approval of the governor and comptroller of the treasury, the attorney general and reporter has the authority to release any pending or future claim of governmental entities against McKesson Corporation, Cardinal Health, Inc., AmerisourceBergen Corporation, Johnson & Johnson, Allergan Finance, LLC, CVS Health Corporation, Teva Pharmaceutical Industries Ltd., Walgreen Co., Walmart Inc., and K-VA-T Food Stores, Inc., and The Kroger Co. and affiliates, subsidiaries, and other entities related to these companies that are released in the McKesson Corporation, Cardinal Health, Inc., AmerisourceBergen Corporation, Johnson & Johnson, Allergan Finance, LLC, CVS Health Corporation, Teva Pharmaceutical Industries Ltd., Walgreen Co., Walmart Inc., and K-VA-T Food Stores, Inc., and The Kroger Co. settlement agreements for activities related to the manufacture, marketing, distribution, dispensing, or sale of opioids, or related activities, if the attorney general deems the release necessary to the interest of the state in the resolution of the opioid crisis.

T.C.A. § 20-13-203

Amended by 2024 Tenn. Acts, ch. 568,s 1, eff. 3/15/2024.
Amended by 2023 Tenn. Acts, ch. 429, s 1, eff. 5/11/2023.
Added by 2021 Tenn. Acts, ch. 491, s 19, eff. 5/24/2021.